El interés en corto de Vinci Partners Inv da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Vinci Partners Inv. Los datos de interés en corto se actualizan cada dos semanas.

Vinci Partners Inv (NASDAQ:VINP) Bolsa, Informe de interés en corto

Vinci Partners Inv

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Vinci Partners Investments Ltd. - Class A Common Shares

Vinci Partners Investments Ltd

Citigroup analyst Ariel Rosa maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Neutral and lowers the price target from $103 to $83.

News

Price Target

Analyst Ratings

ARCB

Citigroup Maintains Neutral on ArcBest, Lowers Price Target to $83

Politics

General

National Security Advisor Waltz Says Ukraine Made Concrete Proposals; Says Talks Got Into Substantive Details On How Ukraine War Will End; Says Rubio Will Meet With G7 Foreign Ministers In Next Couple Of Days; Says Discussed Guarantees Ukraine Will Have For Long-term Security

Investors with a lot of money to spend have taken a bullish stance on Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with FICO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Fair Isaac.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 22%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $190,190, and 6 are calls, for a total amount of $364,040.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $1400.0 and $2340.0 for Fair Isaac, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Fair Isaac's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Fair Isaac's substantial trades, within a strike price spectrum from $1400.0 to $2340.0 over the preceding 30 days.
<h3>Fair Isaac Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741716946_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$14.9</td>
<td>$6.1</td>
<td>$10.0</td>
<td>$1840.00</td>
<td>$150.0K</td>
<td align="right">172</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$221.3</td>
<td>$214.0</td>
<td>$214.0</td>
<td>$1920.00</td>
<td>$85.6K</td>
<td align="right">27</td>
<td align="right">5</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$651.4</td>
<td>$642.0</td>
<td>$646.0</td>
<td>$2340.00</td>
<td>$64.6K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$455.0</td>
<td>$449.9</td>
<td>$455.0</td>
<td>$1400.00</td>
<td>$45.5K</td>
<td align="right">10</td>
<td align="right">4</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$455.0</td>
<td>$451.8</td>
<td>$455.0</td>
<td>$1400.00</td>
<td>$45.5K</td>
<td align="right">10</td>
<td align="right">2</td>
</tr>
</tbody>
</table>

<h3>About Fair Isaac</h3>
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
After a thorough review of the options trading surrounding Fair Isaac, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Fair Isaac Standing Right Now?</h3>
<ul>
<li>With a volume of 101,567, the price of FICO is up 1.24% at $1716.43. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 44 days.</li>
</ul>
<h3>What Analysts Are Saying About Fair Isaac</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $2170.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from RBC Capital has elevated its stance to Outperform, setting a new price target at $2170. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Fair Isaac options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

FICO

Fair Isaac Unusual Options Activity For March 11

Maxim Group analyst Tate Sullivan initiates coverage on Eco Wave Power Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>) with a Buy rating and announces Price Target of $15.

Initiation

WAVE

Maxim Group Initiates Coverage On Eco Wave Power Global with Buy Rating, Announces Price Target of $15

Deep-pocketed investors have adopted a bearish approach towards Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Deere. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 46% bearish. Among these notable options, 7 are puts, totaling $296,745, and 8 are calls, amounting to $279,756.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $420.0 to $570.0 for Deere over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Deere's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Deere's substantial trades, within a strike price spectrum from $420.0 to $570.0 over the preceding 30 days.
<h3>Deere Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741716941_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$64.0</td>
<td>$61.5</td>
<td>$64.0</td>
<td>$500.00</td>
<td>$64.0K</td>
<td align="right">28</td>
<td align="right">10</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$26.1</td>
<td>$25.0</td>
<td>$25.0</td>
<td>$470.00</td>
<td>$62.5K</td>
<td align="right">305</td>
<td align="right">0</td>
</tr>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$35.8</td>
<td>$35.15</td>
<td>$35.15</td>
<td>$510.00</td>
<td>$59.7K</td>
<td align="right">131</td>
<td align="right">17</td>
</tr>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$15.6</td>
<td>$15.6</td>
<td>$15.6</td>
<td>$490.00</td>
<td>$43.6K</td>
<td align="right">204</td>
<td align="right">28</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$11.0</td>
<td>$10.35</td>
<td>$10.7</td>
<td>$450.00</td>
<td>$41.9K</td>
<td align="right">338</td>
<td align="right">68</td>
</tr>
</tbody>
</table>

<h3>About Deere</h3>
Deere is the world's leading manufacturer of agricultural equipment and a major producer of construction machinery. The company is divided into four reporting segments: production &amp; precision agriculture (PPA), small agriculture &amp; turf (SAT), construction &amp; forestry (CF), and financial services (FS), its captive finance subsidiary. The core PPA business is the largest contributor to sales and profits by far. Geographically, Deere sales are 60% US/Canada, 17% Europe, 14% Latin America, and 9% rest of world. Deere goes to market through a robust dealer network that includes over 2,000 dealer locations in North America with reach into over 100 countries. John Deere financial provides retail financing for machinery to its customers and wholesale financing for dealers.
<h3>Present Market Standing of Deere</h3>
<ul>
<li>Trading volume stands at 735,543, with DE's price down by -3.19%, positioned at $473.2.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>What Analysts Are Saying About Deere</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $496.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for Deere, targeting a price of $455. 
&#x2A; In a cautious move, an analyst from Baird downgraded its rating to Neutral, setting a price target of $501. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Neutral rating for Deere, targeting a price of $500. 
&#x2A; In a cautious move, an analyst from Truist Securities downgraded its rating to Buy, setting a price target of $546. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Deere with a target price of $480. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Deere options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Deere's Options Frenzy: What You Need to Know

J.P. Morgan analyst Matthew R. Boss reiterated the Underweight rating on Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>), raising the<a target="_blank" href="https://www.benzinga.com/quote/MTN/analyst-ratings" rel="noreferrer noopener"> price forecast to $167 from $166.</a>
The analyst suggests that while Vail Resorts is well-positioned for the future due to its top-tier resort portfolio, de-risked operating strategy with its Epic Pass options, and a strong customer base of higher-income, avid skiers, four key challenges could impact the business.
These include the normalization of industry trends, leading to a decline in season pass sales to start the year, the saturation of the season pass model, potential resistance to further price increases after three years of 8% hikes, and a shift in customer demographics, Boss writes.
This combination of factors points to potential downside risks in both earnings and the company&#8217;s overall valuation.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/03/44255195/meta-taps-taiwan-semiconductor-to-build-ai-chip-aims-to-cut-nvidia-dependence-by-2026" rel="noreferrer noopener">Meta Taps Taiwan Semiconductor To Build AI Chip, Aims To Cut Nvidia Dependence By 2026</a>
In its second-quarter results released yesterday, the company&nbsp;reported quarterly earnings of&nbsp;$6.56&nbsp;per share, which<a target="_blank" href="https://www.benzinga.com/general/travel/25/03/44236099/vail-resorts-shares-climb-after-q2-results-impress-investors-heres-what-to-know" rel="noreferrer noopener"> beat the consensus estimate of&nbsp;$6.34.</a>
Quarterly revenue came in at $1.14 billion,&nbsp;which met the analyst consensus estimate and is an increase over revenue of $1.08 billion&nbsp;from the prior year&#8217;s quarter.
Boss notes that local visitation has improved year-over-year in the reported quarter, which aligns with internal expectations, driven by more typical weather patterns, especially on the East Coast.
Meanwhile, destination visitation is facing a shift, with consumers delaying their visits to later in the season, resulting in a mixed headwind that impacts ancillary revenue.
Specifically, local guests are spending less than destination guests, leading to a decline in revenue per skier visit.
Despite these shifts, management has confirmed that destination guest spending remains strong, with no signs of a pullback from consumers thus far, even amid ongoing macroeconomic concerns.
Following the results, the analyst models FY25 EPS of $7.39 and FY26 EPS of $7.87.
Price Action: MTN shares are trading higher by 7.02% to $164.37 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44255030/nasdaq-100-trades-below-its-200-day-moving-average-history-says-you-should-buy-the-dip-now" target="_blank" rel="noreferrer noopener">Nasdaq 100 Trades Below Its 200-Day Moving Average: History Says You Should Buy The Dip Now</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Reiteration

Trading Ideas

Vail Resorts Faces Several Headwinds Despite Its Portfolio Strength, Analyst Says

Deep-pocketed investors have adopted a bearish approach towards Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NCLH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Norwegian Cruise Line. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 40% leaning bullish and 53% bearish. Among these notable options, 10 are puts, totaling $622,218, and 5 are calls, amounting to $220,815.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $11.0 and $30.0 for Norwegian Cruise Line, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Norwegian Cruise Line's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Norwegian Cruise Line's significant trades, within a strike price range of $11.0 to $30.0, over the past month.
<h3>Norwegian Cruise Line Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741716936_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.92</td>
<td>$1.72</td>
<td>$1.8</td>
<td>$15.00</td>
<td>$158.4K</td>
<td>4.9K</td>
<td align="right">884</td>
</tr>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$3.95</td>
<td>$3.85</td>
<td>$3.95</td>
<td>$21.00</td>
<td>$97.1K</td>
<td>327</td>
<td align="right">106</td>
</tr>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.0</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$23.00</td>
<td>$67.4K</td>
<td>5.5K</td>
<td align="right">343</td>
</tr>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$1.54</td>
<td>$1.31</td>
<td>$1.54</td>
<td>$17.00</td>
<td>$66.5K</td>
<td>7.9K</td>
<td align="right">432</td>
</tr>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.0</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$23.00</td>
<td>$64.0K</td>
<td>5.5K</td>
<td align="right">343</td>
</tr>
</tbody>
</table>

<h3>About Norwegian Cruise Line</h3>
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
<h3>Present Market Standing of Norwegian Cruise Line</h3>
<ul>
<li>Currently trading with a volume of 10,731,257, the NCLH's price is down by -2.24%, now at $18.32. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 50 days.</li>
</ul>
<h3>Expert Opinions on Norwegian Cruise Line</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $29.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Norwegian Cruise Line, maintaining a target price of $28. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on Norwegian Cruise Line with a target price of $26. 
&#x2A; Consistent in their evaluation, an analyst from Macquarie keeps a Outperform rating on Norwegian Cruise Line with a target price of $31. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Norwegian Cruise Line with a target price of $34. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Norwegian Cruise Line with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

NCLH

Norwegian Cruise Line's Options Frenzy: What You Need to Know

WIIM

LCII

Shares of auto and auto parts stocks are trading lower after President Trump announced additional tariffs on steel and aluminum coming into the US from Canada, which could drive volatility in trade and input costs.

U.S. Secretary Of State Rubio Says Ball Is Now In Russia's Court On Ukraine Peace; Says Ukraine Has Taken Positive Step, We Hope Russians Will Reciprocate

Spruce Point Capital Management has announced a new short position against Remitly Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) as the short seller believes there&#8217;s reason to be skeptical of the company&#8217;s<a href="https://www.benzinga.com/pressreleases/25/03/b44245783/spruce-point-capital-management-announces-investment-opinion-releases-report-and-strong-sell-resea"> financial reporting and valuation</a>.
What To Know: Spruce Point targeted Remitly Global in a new bearish research report that provides evidence of doctored reviews and unreliable accounting practices, suggesting the stock is overvalued.
Benzinga contacted Remitly Global for comment on the report, with a representative responding, &#8220;Thanks for reaching out. We're aware of the report and are in the process of reviewing its claims. I will be back in touch as soon as possible.&#8221;
Remitly is a&nbsp;provider of cross-border remittance services through its mobile app and website. The company relies on positive customer reviews to drive business, according to Spruce Point.
&#8220;Based on our research, we do not believe that Remitly is leading authentically with its customer reviews. We find evidence that Remitly uses stock images and changes the purported names of people depicted in these images on its customer reviews website,&#8221; the short seller said.
See Also: <a href="https://www.benzinga.com/news/25/03/44253100/trump-slaps-50-tariff-on-canadian-steel-aluminum-threatens-auto-industry">Trump Slaps 50% Tariff On Canadian Steel &amp; Aluminum, Threatens Auto Industry</a>
Spruce Point also reported it found evidence that Remitly &#8220;doctored its ratings&#8221; by artificially boosting rating review scores on Trustpilot.
The short seller highlighted recent executive departures and noted that Remitly has reported three areas of weaknesses in its internal control over financial reporting since its IPO in 2021. Furthermore, the company&#8217;s audit and risk committee is currently being led by executives with &#8220;connections to controversial companies.&#8221;
Spruce Point sees multiple headwinds the company is facing including the potential deportation of millions of immigrants as the company relies heavily on serving immigrant customers. The short seller also noted that cryptocurrency, specifically <a href="https://www.benzinga.com/topic/stablecoins">stablecoins</a>, could put pressure on transaction fees and disrupt traditional money remitters like Remitly. 
&#8220;[Remitly] has only one analyst calling it a &#8216;Sell&#8217; while analysts project a consensus target of $29.50 per share implying +47% upside. However, we believe they fail to properly assess the tectonic shift happening in the industry toward stablecoins and crypto payments,&#8221; the short seller said.
Spruce Point highlighted other red flags including the company&#8217;s aggressive issuing of stock-based compensation, the co-founders selling shares through trading plans and the stock&#8217;s premium valuation to peers.
The short seller believes Remitly shares should be trading between $9 and $12 based on a discounted multiple to its closest competitor. 
Spruce Point initiated a short position as it expects shares to underperform industry peers and the broader market moving forward.
RELY Price Action: <a href="http://Benzinga.com/quote/rely">Remitly shares</a> were up 0.75% at $20.22 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44249926/stock-of-the-day-where-will-the-tesla-selloff-end">Stock Of The Day – Where Will The Tesla Selloff End?</a></li>
</ul>
Photo: Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Short Sellers

Short Ideas

RELY

Spruce Point Capital Is Betting Against Remitly Global Stock, Short Seller Says Shares Could Fall To $9 Amid 'Tectonic Shift' Across Industry

Lake Street analyst Ben Haynor maintains Lifeward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) with a Buy and lowers the price target from $4.5 to $4.

LFWD

Lake Street Maintains Buy on Lifeward, Lowers Price Target to $4

Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) with a Buy and lowers the price target from $18 to $13.

SRTS

Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $13

The U.S. government's bold move to establish Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as an official reserve asset through President Donald Trump's strategic Bitcoin reserve (SBR) has thrust cryptocurrencies into the spotlight, yet stablecoins like PayPal's PYUSD <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44252537/xrps-rlusd-stablecoin-has-only-0-7-market-share-what-is-going-on">and Ripple's RLUSD</a> are faltering in their bid for market share against offshore giants like Tether's USDT.
What Happened: Signed into effect on March 6, the executive order designates Bitcoin as a sovereign-grade store of value, backed by roughly 100,000 BTC from forfeited Treasury holdings, while a favorable regulatory climate has failed to ignite adoption of U.S.-based stablecoins.
Analysts point to a paradox: despite unprecedented federal endorsement of digital assets, entrenched transnational players continue to overshadow domestic efforts in the stablecoin arena.
The SBR, detailed in H.C. Wainwright &amp; Co. reports, marks a seismic shift for Bitcoin, which dropped more than 15% to below $80,000 amid investor frustration over vague acquisition plans beyond the initial reserve. 
"The EO states that these coins ‘shall not be sold,'" notes the March 11 report, signaling a long-term U.S. commitment to holding its 198,000 BTC—net of 95,000 owed to Bitfinex—far surpassing Germany's recent 50,000 BTC sale.
Meanwhile, a separate U.S. Digital Asset Stockpile, including 61,000 ETH, points toward Bitcoin's elevated status, as the order prohibits proactive altcoin purchases. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44252537/xrps-rlusd-stablecoin-has-only-0-7-market-share-what-is-going-on">XRP&#8217;s RLUSD Stablecoin Has Only 0.7% Market Share: What Is Going On?</a>
This federal backing, paired with Texas's SB-21 allowing state Bitcoin investments, has analysts predicting a global rush to secure Bitcoin, yet stablecoins tell a different story.
Stablecoins, pegged to the dollar and designed for stability, have enjoyed a Donald Trump administration tailwind, with a supportive Securities and Exchange Commission, a Tether-friendly Commerce Secretary, and relaxed banking rules from the Office of the Comptroller of the Currency. 
Paypal&#8217;s PYUSD and Ripple&#8217;s RLUSD—launched in December as an "enterprise-ready" option on the XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) Ledger—have barely scratched the surface of their target markets.
RLUSD holds less than 0.7% of the stablecoin sector nearly three months post-launch, despite stabilizing at its $1 peg after early volatility. 
PayPal's offering, integrated across its apps and third-party platforms, has similarly struggled, with market forces favoring established players like USDT, USDS and USDE.
"The explicit differentiation firmly elevates Bitcoin above other cryptocurrencies," the March 10 H.C. Wainwright report states, highlighting a policy focus that prioritizes Bitcoin's scarcity and value over stablecoins' transactional utility. 
Tether's dominance persists, bolstered by its offshore roots and widespread use, while U.S.-based contenders grapple with adoption hurdles despite regulatory green lights. 
PayPal has stated it remains committed to PYUSD, dismissing concerns tied to a Biden-era subpoena, and Ripple banks on RLUSD's enterprise appeal, but analysts see little dent in the offshore lead.
What&#8217;s Next: The contrast is stark: Bitcoin's reserve status tightens its supply and boosts institutional credibility, while stablecoins—touted as the future of payments—lag, revealing a market resistant to new entrants even under optimal conditions.
As the U.S. positions itself as a crypto leader, the stablecoin struggle point out to Tether's enduring grip.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44244951/bitcoins-heading-to-73000-without-a-fresh-narrative-10x-research">Bitcoin&#8217;s Heading To $73,000 Without A Fresh Narrative: 10x Research</a></li>
</ul>
Image: Shutterstock

$BTC

$PYUSD

$RLUSD

$USDT

$XRP

Bitcoin Reserve Upgrades Crypto But Paypal, Ripple Stablecoins Lag Behind

TSLA

Tesla shares are trading higher, rebounding after falling on Monday.

Macro Economic Events

Global

Economics

U.S. State Dept Says Both Delegations Agreed To Name Their Negotiating Teams And Immediately Begin Negotiations Toward An Enduring Peace That Provides For Ukraine's Long-Term Security

COLM

LULU

ULTA

Shares of retail and apparel stocks are trading lower following weak guidance from Kohl's, which added to recent consumer concerns.

U.S. State Dept, On Jeddah Meeting Says The U.S. And Ukraine Took Important Steps Toward Restoring Durable Peace For Ukraine; Ukraine Expressed Readiness To Accept The U.S. Proposal To Enact An Immediate, Interim 30-Day Ceasefire; Says The U.S. Will Immediately Lift The Pause On Intelligence Sharing And Resume Security Assistance To Ukraine; U.S.-Ukraine Agreed To Conclude As Soon As Possible A Comprehensive Agreement For Developing Ukraine's Critical Mineral Resources

AMRC, BLD, CISS, CLWT, EFX, FGI, FLNC, KITT, MT, PKX, RIO, RUN, SID, SWK

AMRC

CISS

CLWT

FLNC

KITT

Shares of several companies in the broader industrials space are trading lower amid overall market weakness and tariff concerns.

Throughout the last three months, 4 analysts have evaluated Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $48.5, a high estimate of $55.00, and a low estimate of $44.00. Observing a 17.58% increase, the current average has risen from the previous average price target of $41.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1741716079_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Kodiak Gas Services's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Gabriel Moreen</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Douglas Irwin</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Kodiak Gas Services. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kodiak Gas Services compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Kodiak Gas Services's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Kodiak Gas Services's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KGS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Kodiak Gas Services analyst ratings.</a>
<h2>All You Need to Know About Kodiak Gas Services</h2>
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to primarily fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
<h3>Financial Milestones: Kodiak Gas Services's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Kodiak Gas Services showcased positive performance, achieving a revenue growth rate of 36.97% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Kodiak Gas Services's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 6.17%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Kodiak Gas Services's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.46%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.43%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.95.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Kodiak Gas Services: Insights From 4 Financial Analysts

In the preceding three months, 4 analysts have released ratings for Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Genmab, revealing an average target of $43.0, a high estimate of $50.00, and a low estimate of $27.00. This current average represents a 14.0% decrease from the previous average price target of $50.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1741716065_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Genmab among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Jonathan Chang</td>
<td>Leerink Partners</td>
<td>Announces</td>
<td>Outperform</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Genmab. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Genmab compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Genmab's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Genmab's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GMAB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Genmab analyst ratings.</a>
<h2>About Genmab</h2>
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson &amp; Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson &amp; Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.
<h3>Breaking Down Genmab's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Genmab's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 35.34%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Genmab's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 59.7%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Genmab's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 11.21%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Genmab's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.0% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GMAB

Breaking Down Genmab: 4 Analysts Share Their Views

Press Releases

VINCI PARTNERS TO ANNOUNCE SECOND QUARTER 2024 RESULTS AND HOST WEBCAST AFTER MARKET CLOSE ON WEDNESDAY, AUGUST 07, 2024

Earnings

Dividends

VINCI PARTNERS REPORTS SECOND QUARTER 2024 EARNINGS RESULTS

VINCI PARTNERS TO ANNOUNCE THIRD QUARTER 2024 RESULTS AND HOST WEBCAST AFTER MARKET CLOSE ON THURSDAY, NOVEMBER 07, 2024

Real Estate

VINCI PARTNERS COMPLETES COMBINATION WITH COMPASS

VINCI PARTNERS ANNOUNCES LAUNCH OF NEW FORESTRY STRATEGY WITH THE ACQUISITION OF LACAN

VINCI PARTNERS REPORTS THIRD QUARTER 2024 EARNINGS RESULTS

VINCI PARTNERS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION WITH COMPASS ON NOVEMBER 25TH AT 8:00AM ET

Fintech

VINCI COMPASS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION TODAY AT 8:00AM ET

VINCI COMPASS TO ANNOUNCE FOURTH QUARTER 2024 RESULTS AND HOST CONFERENCE CALL AFTER MARKET CLOSE ON WEDNESDAY, FEBRUARY 26, 2025

Comments

Vinci Partners Inv

Interés en corto

Vinci Partners Inv (NASDAQ:VINP) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL